FrancophonIA/ELRC3.0 huggingface dataset:
English: Week 2 (for boxes of 14, 28, 56, 84) Week 3 (for boxes of 28, 56, 84) Week 4 (for boxes of 28, 56, 84)
Danish: Uge 2 For pakninger med 14, 28, 56 og 84 tabletter Uge 3 For pakninger med 28, 56 og 84 tabletter Uge 4 For pakninger med 28, 56 og 84 tabletter
English: ST segment elevation acute myocardial infarction: clopidogrel should be given as a single daily dose of 75 mg initiated with a 300 mg loading dose in combination with ASA and with or without thrombolytics.
Danish: akut myokardieinfarkt med elevation af ST-segmentet: Behandling med clopidogrel bør bestå af en daglig dosering på 75 mg, indledt med en mætningsdosis på 300 mg i kombination med ASA og med eller uden trombolytika.
English: Seventy-three percent (73%) of patients enrolled into the ACTIVE-A study were unable to take VKA due to physician assessment, inability to comply with INR (international normalised ratio) monitoring, predisposition to falling or head trauma, or specific risk of bleeding; for 26% of the patients, the physician's decision was based on the patient's unwillingness to take VKA.
Danish: 73 % af de inkluderede patienter i ACTIVE-A-studiet kunne ikke tage VKA på grund af en lægelig vurdering, manglende evne til at overholde INR (international normaliseret ratio)-monitorering, disposition for fald eller hovedtraume eller en specifik risiko for blødning.
English: There was an excess of intracranial bleeding in the clopidogrel + ASA treatment group compared to the placebo + ASA group (1.4% versus 0.8%, respectively).
Danish: Der var flere intrakranielle blødninger i clopidogrel + ASA-gruppen sammenlignet med placebo + ASA-gruppen (1,4 % versus 0,8 %, henholdsvis).
English: Strokes occurred in 296 (7.8%) patients receiving clopidogrel + ASA and 408 (10.8%) patients receiving placebo + ASA (relative risk reduction, 28.4%; 95% CI, 16.8% to 38.3%; p=0.00001).
Danish: Apopleksi optrådte hos 296 (7,8 %) af de patienter, der fik clopidogrel + ASA, og hos 408 (10,8 %) af de patienter, der fik placebo + ASA (relativ risikoreduktion 28,4 %; 95 % CI, 16,8 % til 38,3 %, p =
English: Do not stop the treatment unless your doctor tells you so.
Danish: Hvis du holder op med at tage Clopidogrel Mylan Du må ikke stoppe behandlingen medmindre din læge fortæller dig, at du skal gøre det.
English: Within less than 12 hours after regular scheduled time: patients should take the dose immediately and then take the next dose at the regular scheduled time.
Danish: Mindre end 12 timer efter planlagt administration: patienten børskal straks tage den glemte dosis og tage den næste dosis som planlagt.
English: LIST OF EXCIPIENTS It also contains hydrogenated castor oil.
Danish: LISTE OVER HJÆLPESTOFFER Indeholder hydrogeneret ricinusolie.
English: Patients were randomized to receive either prasugrel 5 or 10 mg/d (Days 0-14) (n=1309), or prasugrel 5 or 10 mg/d (Days 0-7) then de-escalated to clopidogrel 75 mg/d (Days 8-14) (n=1309), in combination with ASA (<100 mg/day).
Danish: Patienterne blev randomiseret til at modtage enten prasugrel 5 eller 10 mg/d (dag 0-14) (n = 1309) eller prasugrel 5 eller 10 mg/d (dag 0-7), derefter de-eskaleret til clopidogrel 75 mg/d
English: Non-ST segment elevation acute coronary syndrome (unstable angina or non-Q-wave myocardial infarction): clopidogrel treatment should be initiated with a single 300 mg loading dose and then continued at 75 mg once a day (with acetylsalicylic acid (ASA) 75 mg-325 mg daily).
Danish: Hos patienter med akut koronarsyndrom akut koronarsyndrom uden elevation af ST-segmentet (ustabil angina pectoris eller myokardieinfarkt uden forekomst af Q-takker): Behandling med clopidogrel bør indledes med en enkelt initial mætningsdosis på 300 mg, hvorefter behandlingen består af 75 mg en gang daglig (sammen med acetylsalicylsyre (ASA) 75 mg - 325 mg/dag).
English: Danmark BGP Products ApS Tlf: +45 28116932
Danish: Mylan Denmark ApS Tlf: +45 28116932
English: Patients were randomised to clopidogrel (300 mg loading dose followed by 75 mg/day, N=6,259) or placebo (N=6,303), both given in combination with ASA (75-325 mg once daily) and other standard therapies.
Danish: Patienterne blev randomiseret til clopidogrel (300 mg initial mætningsdosis efterfulgt af 75 mg/dag, N=6.259) eller placebo (N=6.303), begge i kombination med ASA (75-325 mg en gang daglig) samt anden standardbehandling.
English: Fertility Clopidogrel was not shown to alter fertility in animal studies.
Danish: Fertilitet I dyreforsøg blev det ikke vist, at clopidogrel ændrerde fertiliteten.
English: The number of patients experiencing the primary endpoint [cardiovascular (CV) death, myocardial infarction (MI), or stroke] was 582 (9.3%) in the clopidogrel-treated group and 719 (11.4%) in the placebo-treated group, a 20% relative risk reduction (95% CI of 10%-28%; p=0.00009) for the clopidogrel-treated group (17% relative risk reduction when patients were treated conservatively, 29% when they underwent percutaneous transluminal coronary angioplasty (PTCA) with or without stent and 10% when they underwent coronary artery bypass graft (CABG)).
Danish: Antallet af patienter, som oplevede det primære endepunkt [kardiovaskulært dødsfald, myokardieinfarkt eller apopleksi] var 582 (9,3 %) i clopidogrel-gruppen og 719 (11,4 %) i placebogruppen, hvilket giver en relativ risikoreduktion på 20 % (95 % CI: 10 %-28 %; p=0,00009) for clopidogrelgruppen (en relativ risikoreduktion på 17 %, når patienterne fik konservativ behandling, 29 %, når de fik perkutan transluminal koronar angioplasti (PTCA) med eller uden stent, og 10 %, når de fik koronar bypassoperation (CABG)).
English: The major exclusion criteria for patients were documented peptic ulcer disease within the previous 6 months; prior intracerebral hemorrhage; significant thrombocytopenia (platelet count < 50 x 109/l); requirement for clopidogrel or oral anticoagulants (OAC); or intolerance to any of the two compounds.
Danish: Udelukkelseskriteriet var hovedsageligt patienter med følgende sygdomme; dokumenteret peptisk ulcus inden for de sidste 6 måneder, intracerebral blødning i anamnesen, signifikant trombocytopeni (trombocyttal <50 x 10
English: Patients received clopidogrel (300 mg loading dose, followed by 75 mg/day, n=1,752) or placebo (n=1,739), both in combination with ASA (150 to 325 mg as a loading dose, followed by 75 to 162 mg/day), a fibrinolytic agent and, when appropriate, heparin.
Danish: Patienterne fik clopidogrel (300 mg loading dose efterfulgt af 75 mg daglig, n=1.752) eller placebo (n=1.739) begge i kombination med ASA (150--325 mg som loading dose, herefter 75--162- mg daglig), et fibrinolytisk middel samt heparin, når det var hensigtsmæssigt.
English: Do not take Clopidogrel Mylan
Danish: Tag ikke Clopidogrel Mylan:
English: NAME AND ADDRESS OF THE MARKETING AUTHORISATION HOLDER Mylan S.A.S, 117 allée des Parcs, 69 800 Saint Priest, France
Danish: NAVN OG ADRESSE PÅ INDEHAVEREN AF MARKEDSFØRINGSTILLADELSEN Mylan S.A.S, 117 allee des Parcs, 69 800 Saint Priest, Frankrig
English: • if you have a risk of bleeding such as - a medical condition that puts you at risk of internal bleeding (such as a stomach ulcer) - a blood disorder that makes you prone to internal bleeding (bleeding inside any tissues, organs or joints of your body).
Danish: • hvis du har risiko for blødning som f.eks: en medicinsk lidelse, der medfører risiko for indre blødninger (såsom et mavesår) en blødningsforstyrrelse, der giver dig tendens til indre blødning (blødning i et af kroppens væv, organer eller led) en nylig alvorlig skade en nylig operation (herunder tandoperation) en planlagt operation (herunder tandoperation) inden for de næste 7 dage
English: What you need to know before you take Clopidogrel Mylan
Danish: Det skal du vide, før du begynder at tage Clopidogrel Mylan
English: Consistent with the above results, in a meta-analysis including 6 studies of 335 clopidogrel-treated subjects at steady state, it was shown that active metabolite exposure was decreased by 28% for intermediate metabolisers, and 72% for poor metabolisers while platelet aggregation inhibition (5 μM ADP) was decreased with differences in IPA of 5.9% and 21.4%, respectively, when compared to extensive metabolisers.
Danish: I overensstemmelse med resultaterne ovenfor, blev det vist i en metaanalyse af 6 studier med 335 clopidogrelbehandlede ved steady state, at eksponeringen for den aktive metabolit blev nedsat med 28 % hos intermediate metabolisers og med 72 % hos poor metabolisers.
English: Marketing Authorisation Holder Mylan S.A.S, 117 allée des Parcs, 69 800 Saint Priest, France
Danish: INDEHAVER AF MARKEDSFØRINGSTILLADELSEN Mylan S.A.S, 117 allee des Parcs, 69 800 Saint Priest, Frankrig
English: Bleeding and haematological disorders
Danish: Blødning og hæmatologiske sygdommelidelser
English: Clopidogrel Mylan 75 mg film-coated tablets clopidogrel
Danish: Clopidogrel Mylan 75 mg filmovertrukne tabletter clopidogrel
English: The number of patients who reached the primary endpoint (time to first occurrence of stroke, MI, non-CNS systemic embolism or vascular death) was 832 (22.1%) in the group treated with clopidogrel + ASA and 924 (24.4%) in the placebo + ASA group (relative risk reduction of 11.1%; 95% CI of 2.4% to 19.1%; p=0.013), primarily due to a large reduction in the incidence of strokes.
Danish: Antallet af patienter, der nåede det primære endepunkt (tid til første forekomst af apopleksi, MI, nonCNS systemisk emboli eller vaskulær død) var 832 (22,1 %) i gruppen behandlet med clopidogrel + ASA og 924 (24,4 %) i placebo + ASA-gruppen (relativ risikoreduktion 11,1 %; 95 % CI 2,4 % til 19,1 %, p = 0,013).
English: The number of patients experiencing the co-primary endpoint (CV death, MI, stroke or refractory ischaemia) was 1,035 (16.5%) in the clopidogrel-treated group and 1,187 (18.8%) in the placebo-treated group, a 14% relative risk reduction (95% CI of 6%-21%, p=0.0005) for the clopidogrel-treated group.
Danish: Antallet af patienter, som oplevede det primære endepunkt [kardiovaskulært dødsfald, myokardieinfarkt, apopleksi eller refraktær iskæmi] var 1035 (16,5 %) i clopidogrelgruppen og 1.187 (18,8 %) i placebogruppen, hvilket giver en relativ risikoreduktion på 14 % (95 % CI: 6 %-21 %; p=0,00005) for clopidogrelgruppen.
English: In patients who were enrolled in the trial on the sole basis of a recent myocardial infarction, clopidogrel was numerically inferior, but not statistically different from ASA (RRR =
Danish: Hos de patienter, som alene indgik i studiet på grund af et nyligt myokardieinfarkt, lå clopidogrel numerisk lavere, men ikke statistisk forskelligt fra ASA (RRR = -4,0%, CI: -22,5 til 11,7 [p=0,639]).
English: STATEMENT OF ACTIVE SUBSTANCE(S) Each film-coated tablet contains 75 mg of clopidogrel (as hydrochloride).
Danish: ANGIVELSE AF AKTIVT STOF/AKTIVE STOFFER Hver filmovertrukken tablet indeholder 75 mg clopidogrel (som hydrochlorid).
English: TOPIC (Timing Of Platelet Inhibition after acute Coronary syndrome) This randomized, open-label trial included ACS patients requiring PCI.
Danish: Dette randomiseret, open-label studie inkluderede ACS patienter, som kræver PCI.
English: This leaflet was last revised in MM/YYYY.
Danish: DATO FOR ÆNDRING AF TEKSTEN <MM/ÅÅÅÅ>
English: Epistaxis
Danish: Κύπρος
English: Mylan bvba/sprl /Tel: + 32 (0)2 658 61 00 (Belgique/Belgien)
Danish: Tel: + 32 (0)2 658 61 00 (Belgique/Belgien)
English: Secondary prevention of atherothrombotic events
Danish: Sekundær forebyggelse af aterotrombotiske hændelser Clopidogrel er indiceret hos:
English: fluconazole or voriconazole, medicines to treat fungal infections, anti-retroviral medicines (medicines to treat HIV infections) carbamazepine, a medicine to treat some forms of epilepsy, moclobemide, medicine to treat depression, repaglinide, medicine to treat diabetes, paclitaxel, medicine to treat cancer.
Danish: o heparin eller anden medicin til indsprøjtning, for at nedsætte dannelse af blodpropper, o ticlopidin, der er anden medicin mod blodpropper, o selektive serotoningenoptagelseshæmmere (inklusive, men ikke begrænset til fluoxetin og fluvoxamin), der normalt anvendes mod depression, omeprazol eller esomeprazol til behandling af for meget mavesyre, fluconazol eller voriconazol, der anvendes til behandling af svampeinfektioner, antiretrovirale lægemidler (HIV-medicin), carbamazepin, , medicin der anvendes mod bestemte former for epilepsi, moclobemid, medicin mod depression, repaglinid, medicin til behandling af diabetes, paclitaxel, medicin til behandling af kræft.
English: You should specifically tell your doctor if you take medicines that may increase your risk of bleeding such as: o oral anticoagulants, medicines used to reduce blood clotting, o a non-steroidal anti-inflammatory medicine, usually used to treat painful and/or inflammatory conditions of muscle or joints, o heparin, or any other injectable medicine used to reduce blood clotting, o ticlopidine, other antiplatelet agent, o a selective serotonin reuptake inhibitor (including but not restricted to fluoxetine or fluvoxamine), medicines usually used to treat depression, omeprazole or esomeprazole, medicines to treat upset stomach,
Danish: Det er særlig vigtigt, at du fortæller det til din læge, hvis du tager medicin, der kan øge risikoen for blødning, såsom: o blodfortyndende medicin, der tages gennem munden og avendes til at nedsætte dannelse af blodpropper, o en type smertestillende medicin (nonsteroide antiinflammatoriske lægemidler, NSAID'er), som normalt gives til behandling af smertefulde og/eller betændelseslignende tilstande i muskler eller led,
English: 4.2 Posology and method of administration Posology
Danish: 4.2 Dosering og administration
English: Τηλ: + 357 99403969
Danish: Pharmaceutical Trading Co Ltd Τηλ: + 357 99403969
English: How to take Clopidogrel Mylan
Danish: Sådan skal du tage Clopidogrel Mylan
English: NAME OF THE MEDICINAL PRODUCT Clopidogrel Mylan 75 mg film-coated tablets
Danish: LÆGEMIDLETS NAVN Clopidogrel Mylan 75 mg filmovertrukne tabletter
English: NAME OF THE MEDICINAL PRODUCT Clopidogrel Mylan 75 mg film-coated tablets clopidogrel
Danish: LÆGEMIDLETS NAVN Clopidogrel Mylan 75 mg filmovertrukne tabletter clopidogrel
English: What Clopidogrel Mylan looks like and contents of the pack The film-coated tablets are pink, round and biconvex.
Danish: De filmovertrukne tabletter er lyserøde, runde og bikonvekse.
English: What Clopidogrel Mylan contains The active substance is clopidogrel.
Danish: Clopidogrel Mylan 75 mg filmovertrukne tabletter indeholder: Det aktive stof er clopidogrel.
English: 84 film-coated tablets: EU/1/09/559/007
Danish: 84 filmovertrukne tabletter: EU/1/09/559/007
English: 90 film-coated tablets: EU/1/09/559/008
Danish: 90 filmovertrukne tabletter: EU/1/09/559/008
English: Gynaecomastia
Danish: Atrieflimren
English: Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines, including medicines obtained without a prescription.
Danish: Brug af anden medicin sammen med Clopidogrel Mylan Fortæl altid lægen eller apotekspersonalet, hvis du tager anden medicin eller har gjort det for nylig.
English: 56 film-coated tablets: EU/1/09/559/006
Danish: 56 filmovertrukne tabletter: EU/1/09/559/006
English: 7 film-coated tablets: EU/1/09/559/001
Danish: 7 filmovertrukne tabletter: EU/1/09/559/001
English: 28 film-coated tablets: EU/1/09/559/003
Danish: 28 filmovertrukne tabletter: EU/1/09/559/003
English: Proton Pump Inhibitors (PPI):
Danish: Syrepumpehæmmere (PPI)
English: 14 film-coated tablets: EU/1/09/559/002
Danish: 14 filmovertrukne tabletter: EU/1/09/559/002
English: Ask your doctor or pharmacist for advice before taking any medicine.
Danish: Spørg lægen eller apotekspersonalet, hvis der er mere, du vil vide.
English: heparin, glycoprotein IIb/IIIa inhibitors or non-steroidal anti-inflammatory drugs (NSAIDs) including Cox-2 inhibitors, or selective serotonin reuptake inhibitors (SSRIs), or other medicinal products associated with bleeding risk such as pentoxifylline (see section 4.5).
Danish: Ligesom andre antitrombolytika skal clopidogrel anvendes med forsigtighed til patienter med risiko for tiltagende blødninger pga. traumer, kirurgi eller andre patologiske tilstande samt til patienter, der samtidigt behandles med ASA, heparin, glycoprotein IIb/IIIa-hæmmere, non-steroide antiinflammatoriske lægemidler (NSAID'er) inklusive cox-2-hæmmere eller selektive serotoningenoptagelseshæmmere (SSRI'er), eller ande lægemidler forbundet med risiko for blødning, såsom pentoxifyllin (se pkt.
English: 30 film-coated tablets: EU/1/09/559/004
Danish: 30 filmovertrukne tabletter: EU/1/09/559/004
English: Serum sickness, anaphylactoid reactions, cross-reactive drug hypersensitivity among thienopyridines (such as ticlopidine, prasugrel) (see section 4.4), insulin autoimmune syndrome, which can lead to severe hypoglycemia, particularly in patients with HLA DRA4 subtype (more frequent in the Japanese population)*
Danish: Serumsygdom, anafylaktiske reaktioner, krydsallergiske reaktioner mellem thienopyridiner (såsom ticlopidin, prasugrel) (se pkt.
English: 50 film-coated tablets: EU/1/09/559/005
Danish: 50 filmovertrukne tabletter: EU/1/09/559/005
English: Tel: + 34 900 102 712
Danish: Mylan Pharmaceuticals, S.L Tel: + 34 900 102 712
English: You have a condition of hardening of arteries (also known as atherosclerosis), and You have previously experienced a heart attack, stroke or have a condition known as peripheral arterial disease, or
Danish: Du har fået ordineret Clopidogrel Mylan til forebyggelse af blodpropper og nedsættelse af risikoen for disse alvorlige hændelser, fordi: du lider af åreforkalkning (også kaldet aterosklerose) - og du tidligere har haft et hjerteanfald, apopleksi eller kredsløbsforstyrrelser i arme eller ben - eller du har haft en alvorlig form for smerter i brystet, som kaldes hjertekrampe (ustabil angina pectoris) eller hjerteanfald (myokardieinfarkt).
English: Mon Tue Wed Thu Fri Sat Sun
Danish: Ma Ti On To Fr Lø Sø
English: Luxembourg/Luxemburg
Danish: Luxembourg/Luxemburg Mylan bvba/sprl
English: • Bioequivalence vis-à-vis a valid EU reference medicinal product has been demonstrated, based on relevant data, in accordance with the requirements of Article 10 of Directive 2001/83/EC (e.g. a bioequivalence study conducted vis-à-vis the EU reference medicinal product).
Danish: • Bioækvivalens med et godkendt EU-referencelægemiddel er blevet påvist på grundlag af relevante data i overensstemmelse med kravene i artikel 10 i direktiv 2001/83/EF (f.eks. en undersøgelse af bioækvivalensen med det pågældende EU-referencelægemiddel).
English: For the suspension of the marketing authorisations to be lifted, the competent authorities of the EU Member States shall ensure that the below condition has been completed by the marketing authorisation holders
Danish: For at kunne ophæve suspenderingen af markedsføringstilladelserne skal de kompetente myndigheder i EU's medlemsstater sikre, at nedenstående betingelse er opfyldt af markedsføringstilladelsesindehaverne:
English: These can be taken from you or from a donor.
Danish: De kan tages fra Dem selv eller fra en donor.
English: It is important to tell your doctor if you:
Danish: Det er vigtigt, at De fortæller lægen, hvis De:
English: You should talk to your doctor about your risks of developing cancers of the blood and what testing should be done.
Danish: De bør tale med Deres læge om risikoen for at udvikle blodkræft, og hvilke undersøgelser der skal udføres.
English: Do not warm Ratiograstim in any other way (for example, do not warm it in a microwave or in hot water).
Danish: De må ikke opvarme Ratiograstim på anden vis (for eksempel hverken ved at lægge den i mikroovnen eller i varmt vand).
English: If you are a stem cell donor, you must be aged between 16 and 60 years.
Danish: Hvis De er stamcelledonor, skal De være mellem 16 og 60 år.
English: Sixty-five percent of the patients studied in the SCN trial programme were under 18 years of age.
Danish: 65 % af de patienter, der indgik i SCN-studieprogrammet, var under 18 år.
English: 08409 Vilnius Lithuania
Danish: 08409 Vilnius Litauen
English: You may experience the following side effects:
Danish: De kan få følgende bivirkninger:
English: Infants and young children (below 2 years of age) may not yet be diagnosed with HFI.
Danish: Spædbørn og småbørn (under 2 år) har måske endnu ikke fået konstateret HFI.
English: The usual dose varies depending on your illness and weight.
Danish: Den normale dosis afhænger af Deres sygdom og vægt.
English: 4.8 Undesirable effects a. Summary of the safety profile
Danish: 4.8 Bivirkninger a. Oversigt over sikkerhedsprofil
English: A detailed history of HFI symptoms has to be taken of each patient before giving this medicinal product.
Danish: Der skal tages en detaljeret anamnese med HFI-symptomer for hver patient, før dette lægemiddel gives.
English: For patients who have not had extensive chemotherapy, one leukapheresis is often sufficient.
Danish: Hos patienter, som ikke har fået omfattende kemoterapi, er en enkelt leukaferese ofte tilstrækkeligt.
English: Name and address of the manufacturer of the biological active substance SICOR Biotech UAB
Danish: Navn og adresse på fremstilleren af det biologisk aktive stof SICOR Biotech UAB
English: It is advisable to wait and see how you feel after using this medicine and before driving or operating machinery.
Danish: Det tilrådes, at De venter og ser, hvordan De har det, når De har taget dette lægemiddel, før De fører motorkøretøj eller betjener maskiner.
English: You, or people caring for you, can be taught how to give subcutaneous injections so that you can continue your treatment at home.
Danish: De eller Deres plejere kan lære, hvordan injektioner under huden gives, så De kan fortsætte Deres behandling derhjemme.
English: Thereafter, it is recommended that the ANC is measured at least twice weekly for the first two weeks and subsequently once per week or once every other week during maintenance therapy.
Danish: Derefter anbefales det at bestemme ANC mindst to gange ugentligt i de første 2 uger og derefter en gang ugentligt eller en gang hver anden uge under resten af behandlingen.
English: Medicinal products (containing sorbitol/fructose) given intravenously may be life-threatening and should not be given in this population unless there is an overwhelming clinical need and no alternatives are available.
Danish: Lægemidler (med sorbitol/fructose), som gives intravenøst, kan være livstruende og må ikke gives til denne population, medmindre der er et overvældende klinisk behov og ingen alternativer til rådighed.
English: When the response has been obtained, the minimal effective dose to maintain this level should be established.
Danish: Når der er opnået respons, bør den mindste dosis, der effektivt kan opretholde dette niveau, fastlægges.
English: The additive effect of concomitantly given products containing sorbitol (or fructose) and dietary intake of sorbitol (or fructose) should be taken into account.
Danish: Der skal tages højde for den additive effekt af samtidigt indgivne produkter, som indeholder sorbitol (eller fructose) og indtag af sorbitol (eller fructose) i kosten.
English: Your doctor may regularly test your urine if you experience this side effect or if protein is found in your urine (proteinuria).
Danish: Deres læge vil muligvis kontrollere Deres urin regelmæssigt, hvis De får denne bivirkning, eller hvis der konstateres protein i Deres urin (proteinuri).
English: Causes of transient neutropenia such as viral infections should be excluded.
Danish: Årsager til forbigående neutropeni som f. eks. virusinfektioner bør udelukkes.
English: Your doctor may want to monitor you closely, see section 4 of the package leaflet.
Danish: Deres læge vil måske overvåge Deres tilstand nøje, se punkt 4 i indlægssedlen.
English: If you have missed an injection, or injected too little, contact your doctor as soon as possible.
Danish: Hvis De har sprunget en indsprøjtning over eller injiceret en for lille dosis, skal De kontakte Deres læge hurtigst muligt.
English: In other circumstances, additional leukapheresis may be necessary.
Danish: Under andre omstændigheder kan der være behov for flere leukafereser.